Get Live Data

focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

  2. Media
  3. Poolbeg Pharma: Further data shows POLB001 potential in cancer CRS

Poolbeg Pharma: Further data shows POLB001 potential in cancer CRS

17th January 2024
Share Views
Runtime 01:26

Key highlights from today's POLB RNS include:

- Efficacy is demonstrated in reducing cancer immunotherapy-induced CRS in an in vivo model

- New data strengthens and facilitates the expansion of patent applications for POLB 001 in cancer immunotherapy-induced CRS.

Read the full RNS here.

Poolbeg CEO Jeremy Skillington gave a POLB 001 update & explained how they use AI to speed discovery

1st March 2023

Four CEO's present on London South East 8.11.2022: ValiRx, Poolbeg Pharma, enCore Energy, Goldplat

10th November 2022

Jeremy Skillington expects strong newsflow in the next few months for Poolbeg Pharma

9th November 2022

Related Shares

Poolbeg Pharma (POLB)
12.60 (-0.35 / -2.66%)
12.50 - 12.70
Back to Media

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.